Your browser doesn't support javascript.
loading
Pooled resistance analyses of darunavir once-daily regimens and formulations across 10 clinical studies of treatment-naïve and treatment-experienced patients with human immunodeficiency virus-1 infection.
Lathouwers, Erkki; Seyedkazemi, Sareh; Luo, Donghan; Brown, Kimberley; De Meyer, Sandra; Wong, Eric Y.
Affiliation
  • Lathouwers E; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Seyedkazemi S; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.
  • Luo D; Janssen Research & Development, LLC, Titusville, NJ, USA.
  • Brown K; Janssen Research & Development, LLC, Titusville, NJ, USA.
  • De Meyer S; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Wong EY; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.
HIV Res Clin Pract ; 21(2-3): 83-89, 2020.
Article in En | MEDLINE | ID: mdl-32715952
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Clinical Trials as Topic / HIV-1 / Anti-HIV Agents / Drug Resistance, Viral / Darunavir Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: HIV Res Clin Pract Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Clinical Trials as Topic / HIV-1 / Anti-HIV Agents / Drug Resistance, Viral / Darunavir Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: HIV Res Clin Pract Year: 2020 Document type: Article Affiliation country: Country of publication: